Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caveolin-2 is a small integral membrane protein (~20 kDa) that forms a major component of caveolae, specialized invaginations of the plasma membrane enriched in cholesterol and sphingolipids. Caveolin-2 tightly interacts with caveolin-1 to form hetero-oligomeric complexes necessary for proper caveolae assembly and cell surface localization. It regulates multiple cell functions, including signaling, lipid metabolism, cell growth, and apoptosis. Caveolin-2 is typically phosphorylated at specific serine residues, which modulate its ability to regulate caveolae formation and function. While caveolin-2’s role is less defined than caveolin-1, it is increasingly recognized as an important contributor to disease biology, especially in cancer and cardiovascular contexts. Its function is tissue- and cell-type specific, reflecting context-dependent interactions and signaling regulation. Caveolin-2 interacts most directly with caveolin-1, is phosphorylated by Src and casein kinase II, and has been implicated more recently in direct signaling roles distinct from caveolin-1, particularly in the context of disease. There are currently no direct therapeutics for caveolin-2, but its significance in pathology and its biomarker potential make it an emerging focus in translational medicine.
Not directly applicable; caveolin-2 modulates caveolae-associated signaling and function, often by scaffolding and regulating the availability/activity of signaling molecules, especially via phosphorylation states.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caveolin-2 (CAV2).